Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ELITE PHARMACEUTICALS INC /NV/Listing on record | Buy | $9.7K | conv 68First in 12mo | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | AwardD (derivative) | $120K | SEC |